MedTech News
Dornier MedTech America launches Hoover™ and AXIS® II SLIM, raising the bar in kidney stone treatment
KENNESAW, Ga., Sept. 17, 2025 /PRNewswire/ — Dornier MedTech America (DMTA) has announced the full U.S. commercial launch of its Dornier Hoover Flexible and Navigable Suction Ureteral Access Sheath (FANS) and Dornier Axis II Slim single-use ureteroscope with a 5.6Fr. distal tip.
SutureTech Announces FDA 510(k) Clearance for RapidFix™,Its All – Suture Staple Device for Soft Tissue Repair
Durham, NC — September 16, 2025 — SutureTech, a surgeon-founded medical device company focused on advancing soft tissue and tendon repair, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for RapidFix™, its flagship device.
Moberg Analytics Launches AI Platform for Brain-Injured Patients
The Moberg Clinical Platform brings advanced analytics and AI to critical care, offering clinicians new insights into brain function that can directly inform patient management
Body Vision Medical Receives Regulatory Approval for LungVision® in India, Expanding Access to AI-Driven Advanced Imaging for Lung Cancer Diagnosis
WALTHAM, Mass., Sept. 16, 2025 /PRNewswire/ — Body Vision Medical, a global leader in AI-powered intraoperative imaging, is proud to announce that its LungVision AI-powered advanced imaging system has received regulatory approval from the Central Drugs Standard Control Organization (CDSCO) in India. This approval marks a significant milestone in the company’s mission to improve early and accurate lung cancer diagnosis worldwide.
AI spots hidden signs of depression in students’ facial expressions
Depression is one of the most common mental health challenges, but its early signs are often overlooked. It is often linked to reduced facial expressivity.
AI algorithm turns mammograms into a ‘two-for-one’ test for women’s heart health
An AI algorithm based only on routine mammogram images plus age can predict a woman’s risk of major cardiovascular disease as well as standard risk assessment methods, finds research published online in the journal Heart.
AI-powered CRISPR could lead to faster gene therapies
Stanford Medicine researchers have developed an artificial intelligence tool to help scientists better plan gene-editing experiments. The technology, CRISPR-GPT, acts as a gene-editing “copilot” supported by AI to help researchers—even those unfamiliar with gene editing—generate designs, analyze data and troubleshoot design flaws.
FDA clears accelerated protocol for BrainsWay Deep TMS in depression
BrainsWay (Nasdaq:BWAY) today announced the FDA granted expanded clearance for its Deep Transcranial Magnetic Stimulation system to include an accelerated treatment protocol for major depressive disorder and patients with comorbid anxiety symptoms.